Advertisement

Index by author

September 01, 1994; Volume 46,Issue 3

A

  1. Akeson, M

    1. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
      R V Benya, M Akeson, J Mrozinski, R T Jensen and J F Battey
      Molecular Pharmacology September 1994, 46 (3) 495-501;

  2. Alifimoff, J K

    1. Does general anesthetic-induced desensitization of the Torpedo acetylcholine receptor correlate with lipid disordering?
      L L Firestone, J K Alifimoff and K W Miller
      Molecular Pharmacology September 1994, 46 (3) 508-515;

  3. Amara, S G

    1. Stable expression of a neuronal gamma-aminobutyric acid transporter, GAT-3, in mammalian cells demonstrates unique pharmacological properties and ion dependence.
      J A Clark and S G Amara
      Molecular Pharmacology September 1994, 46 (3) 550-557;

  4. Anand, R

    1. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
      X Peng, V Gerzanich, R Anand, P J Whiting and J Lindstrom
      Molecular Pharmacology September 1994, 46 (3) 523-530;

B

  1. Bard, J A

    1. The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;

  2. Barret, J M

    1. A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
      J M Barret, P Calsou, A K Larsen and B Salles
      Molecular Pharmacology September 1994, 46 (3) 431-436;

  3. Battey, J F

    1. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
      R V Benya, M Akeson, J Mrozinski, R T Jensen and J F Battey
      Molecular Pharmacology September 1994, 46 (3) 495-501;

  4. Beavo, J A

    1. Multiple cyclic nucleotide phosphodiesterases.
      J A Beavo, M Conti and R J Heaslip
      Molecular Pharmacology September 1994, 46 (3) 399-405;

  5. Benya, R V

    1. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
      R V Benya, M Akeson, J Mrozinski, R T Jensen and J F Battey
      Molecular Pharmacology September 1994, 46 (3) 495-501;

  6. Berg, K A

    1. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
      K A Berg, W P Clarke, C Sailstad, A Saltzman and S Maayani
      Molecular Pharmacology September 1994, 46 (3) 477-484;

  7. Bertilsson, L

    1. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
      I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg
      Molecular Pharmacology September 1994, 46 (3) 452-459;

  8. Birnbaumer, L

    1. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density.
      X Zhu, S Gilbert, M Birnbaumer and L Birnbaumer
      Molecular Pharmacology September 1994, 46 (3) 460-469;

  9. Birnbaumer, M

    1. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density.
      X Zhu, S Gilbert, M Birnbaumer and L Birnbaumer
      Molecular Pharmacology September 1994, 46 (3) 460-469;

  10. Bonanno, G

    1. Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
      A Gemignani, P Paudice, G Bonanno and M Raiteri
      Molecular Pharmacology September 1994, 46 (3) 558-562;

  11. Boring, D

    1. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

  12. Bouchard, B

    1. Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
      R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret
      Molecular Pharmacology September 1994, 46 (3) 445-451;

  13. Branchek, T A

    1. The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;

  14. Brown, J H

    1. Rapid heterologous desensitization of muscarinic and thrombin receptor-mediated phospholipase D activation.
      M Nieto, E Kennedy, D Goldstein and J H Brown
      Molecular Pharmacology September 1994, 46 (3) 406-413;

C

  1. Calsou, P

    1. A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
      J M Barret, P Calsou, A K Larsen and B Salles
      Molecular Pharmacology September 1994, 46 (3) 431-436;

  2. Cantrell, C H

    1. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

  3. Clark, J A

    1. Stable expression of a neuronal gamma-aminobutyric acid transporter, GAT-3, in mammalian cells demonstrates unique pharmacological properties and ion dependence.
      J A Clark and S G Amara
      Molecular Pharmacology September 1994, 46 (3) 550-557;

  4. Clarke, W P

    1. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
      K A Berg, W P Clarke, C Sailstad, A Saltzman and S Maayani
      Molecular Pharmacology September 1994, 46 (3) 477-484;

  5. Conti, M

    1. Multiple cyclic nucleotide phosphodiesterases.
      J A Beavo, M Conti and R J Heaslip
      Molecular Pharmacology September 1994, 46 (3) 399-405;

  6. Cook, J M

    1. Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;

  7. Coulomb, B

    1. Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
      R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret
      Molecular Pharmacology September 1994, 46 (3) 445-451;

D

  1. Dettbarn, C

    1. Many agonists induce "quantal" Ca2+ release or adaptive behavior in muscle ryanodine receptors.
      C Dettbarn, S Györke and P Palade
      Molecular Pharmacology September 1994, 46 (3) 502-507;

  2. Diaz-Araúzo, H

    1. Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;

  3. Dorai, T

    1. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
      T Dorai, H Kobayashi, J F Holland and T Ohnuma
      Molecular Pharmacology September 1994, 46 (3) 437-444;

  4. Dubertret, L

    1. Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
      R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret
      Molecular Pharmacology September 1994, 46 (3) 445-451;

E

  1. Evans, D M

    1. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

F

  1. Farb, D H

    1. Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma-aminobutyric acid type A receptor.
      M Gyenes, Q Wang, T T Gibbs and D H Farb
      Molecular Pharmacology September 1994, 46 (3) 542-549;

  2. Firestone, L L

    1. Does general anesthetic-induced desensitization of the Torpedo acetylcholine receptor correlate with lipid disordering?
      L L Firestone, J K Alifimoff and K W Miller
      Molecular Pharmacology September 1994, 46 (3) 508-515;

  3. Forray, C

    1. The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;

G

  1. Ge, J L

    1. Specificity and directionality of thiol effects on sinusoidal glutathione transport in rat liver.
      S C Lu, J Kuhlenkamp, J L Ge, W M Sun and N Kaplowitz
      Molecular Pharmacology September 1994, 46 (3) 578-585;

  2. Gemignani, A

    1. Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
      A Gemignani, P Paudice, G Bonanno and M Raiteri
      Molecular Pharmacology September 1994, 46 (3) 558-562;

  3. Gerzanich, V

    1. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
      X Peng, V Gerzanich, R Anand, P J Whiting and J Lindstrom
      Molecular Pharmacology September 1994, 46 (3) 523-530;

  4. Gibbs, T T

    1. Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma-aminobutyric acid type A receptor.
      M Gyenes, Q Wang, T T Gibbs and D H Farb
      Molecular Pharmacology September 1994, 46 (3) 542-549;

  5. Gilbert, S

    1. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density.
      X Zhu, S Gilbert, M Birnbaumer and L Birnbaumer
      Molecular Pharmacology September 1994, 46 (3) 460-469;

  6. Goldstein, D

    1. Rapid heterologous desensitization of muscarinic and thrombin receptor-mediated phospholipase D activation.
      M Nieto, E Kennedy, D Goldstein and J H Brown
      Molecular Pharmacology September 1994, 46 (3) 406-413;

  7. Guengerich, F P

    1. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;

  8. Guo, Z

    1. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;

  9. Gyenes, M

    1. Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma-aminobutyric acid type A receptor.
      M Gyenes, Q Wang, T T Gibbs and D H Farb
      Molecular Pharmacology September 1994, 46 (3) 542-549;

  10. Györke, S

    1. Many agonists induce "quantal" Ca2+ release or adaptive behavior in muscle ryanodine receptors.
      C Dettbarn, S Györke and P Palade
      Molecular Pharmacology September 1994, 46 (3) 502-507;

H

  1. Harbon, S

    1. Endothelin receptor type A signals both the accumulation of inositol phosphates and the inhibition of cyclic AMP generation in rat myometrium: stimulation and desensitization.
      L D Khac, S Naze and S Harbon
      Molecular Pharmacology September 1994, 46 (3) 485-494;

  2. Heaslip, R J

    1. Multiple cyclic nucleotide phosphodiesterases.
      J A Beavo, M Conti and R J Heaslip
      Molecular Pharmacology September 1994, 46 (3) 399-405;

  3. Holland, J F

    1. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
      T Dorai, H Kobayashi, J F Holland and T Ohnuma
      Molecular Pharmacology September 1994, 46 (3) 437-444;

  4. Howlett, A C

    1. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

I

  1. Ingelman-Sundberg, M

    1. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
      I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg
      Molecular Pharmacology September 1994, 46 (3) 452-459;

  2. Inoue, K

    1. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;

  3. Izumi, F

    1. Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;

J

  1. Jensen, R T

    1. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
      R V Benya, M Akeson, J Mrozinski, R T Jensen and J F Battey
      Molecular Pharmacology September 1994, 46 (3) 495-501;

  2. Johansson, I

    1. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
      I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg
      Molecular Pharmacology September 1994, 46 (3) 452-459;

  3. Johnson, M R

    1. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

K

  1. Kaplowitz, N

    1. Specificity and directionality of thiol effects on sinusoidal glutathione transport in rat liver.
      S C Lu, J Kuhlenkamp, J L Ge, W M Sun and N Kaplowitz
      Molecular Pharmacology September 1994, 46 (3) 578-585;

  2. Kennedy, E

    1. Rapid heterologous desensitization of muscarinic and thrombin receptor-mediated phospholipase D activation.
      M Nieto, E Kennedy, D Goldstein and J H Brown
      Molecular Pharmacology September 1994, 46 (3) 406-413;

  3. Khac, L D

    1. Endothelin receptor type A signals both the accumulation of inositol phosphates and the inhibition of cyclic AMP generation in rat myometrium: stimulation and desensitization.
      L D Khac, S Naze and S Harbon
      Molecular Pharmacology September 1994, 46 (3) 485-494;

  4. Kobayashi, H

    1. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
      T Dorai, H Kobayashi, J F Holland and T Ohnuma
      Molecular Pharmacology September 1994, 46 (3) 437-444;

  5. Kuhlenkamp, J

    1. Specificity and directionality of thiol effects on sinusoidal glutathione transport in rat liver.
      S C Lu, J Kuhlenkamp, J L Ge, W M Sun and N Kaplowitz
      Molecular Pharmacology September 1994, 46 (3) 578-585;

L

  1. La Loggia, A J

    1. Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;

  2. Larsen, A K

    1. A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
      J M Barret, P Calsou, A K Larsen and B Salles
      Molecular Pharmacology September 1994, 46 (3) 431-436;

  3. Laz, T M

    1. The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;

  4. Lebreton, C

    1. Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
      R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret
      Molecular Pharmacology September 1994, 46 (3) 445-451;

  5. Le Panse, R

    1. Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
      R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret
      Molecular Pharmacology September 1994, 46 (3) 445-451;

  6. Lindstrom, J

    1. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
      X Peng, V Gerzanich, R Anand, P J Whiting and J Lindstrom
      Molecular Pharmacology September 1994, 46 (3) 523-530;

  7. Lu, S C

    1. Specificity and directionality of thiol effects on sinusoidal glutathione transport in rat liver.
      S C Lu, J Kuhlenkamp, J L Ge, W M Sun and N Kaplowitz
      Molecular Pharmacology September 1994, 46 (3) 578-585;

  8. Lyon, K L

    1. Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;

M

  1. Maayani, S

    1. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
      K A Berg, W P Clarke, C Sailstad, A Saltzman and S Maayani
      Molecular Pharmacology September 1994, 46 (3) 477-484;

  2. Miller, K W

    1. Does general anesthetic-induced desensitization of the Torpedo acetylcholine receptor correlate with lipid disordering?
      L L Firestone, J K Alifimoff and K W Miller
      Molecular Pharmacology September 1994, 46 (3) 508-515;

  3. Mimura, M

    1. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;

  4. Mitev, V

    1. Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
      R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret
      Molecular Pharmacology September 1994, 46 (3) 445-451;

  5. Miyamoto, E

    1. Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;

  6. Mrozinski, J

    1. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
      R V Benya, M Akeson, J Mrozinski, R T Jensen and J F Battey
      Molecular Pharmacology September 1994, 46 (3) 495-501;

N

  1. Naze, S

    1. Endothelin receptor type A signals both the accumulation of inositol phosphates and the inhibition of cyclic AMP generation in rat myometrium: stimulation and desensitization.
      L D Khac, S Naze and S Harbon
      Molecular Pharmacology September 1994, 46 (3) 485-494;

  2. Nieto, M

    1. Rapid heterologous desensitization of muscarinic and thrombin receptor-mediated phospholipase D activation.
      M Nieto, E Kennedy, D Goldstein and J H Brown
      Molecular Pharmacology September 1994, 46 (3) 406-413;

O

  1. Ohnuma, T

    1. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
      T Dorai, H Kobayashi, J F Holland and T Ohnuma
      Molecular Pharmacology September 1994, 46 (3) 437-444;

  2. Ohta, Y

    1. Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;

  3. Oscarson, M

    1. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
      I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg
      Molecular Pharmacology September 1994, 46 (3) 452-459;

P

  1. Palade, P

    1. Many agonists induce "quantal" Ca2+ release or adaptive behavior in muscle ryanodine receptors.
      C Dettbarn, S Györke and P Palade
      Molecular Pharmacology September 1994, 46 (3) 502-507;

  2. Patterson, F K

    1. Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;

  3. Paudice, P

    1. Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
      A Gemignani, P Paudice, G Bonanno and M Raiteri
      Molecular Pharmacology September 1994, 46 (3) 558-562;

  4. Peng, X

    1. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
      X Peng, V Gerzanich, R Anand, P J Whiting and J Lindstrom
      Molecular Pharmacology September 1994, 46 (3) 523-530;

  5. Persmark, M

    1. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;

  6. Pinto, J C

    1. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

  7. Potié, F

    1. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

R

  1. Raiteri, M

    1. Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
      A Gemignani, P Paudice, G Bonanno and M Raiteri
      Molecular Pharmacology September 1994, 46 (3) 558-562;

  2. Reddy, M S

    1. Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;

  3. Rice, K C

    1. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

  4. Richelson, E

    1. Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
      M Yamada, M Yamada, M A Watson and E Richelson
      Molecular Pharmacology September 1994, 46 (3) 470-476;

S

  1. Sailstad, C

    1. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
      K A Berg, W P Clarke, C Sailstad, A Saltzman and S Maayani
      Molecular Pharmacology September 1994, 46 (3) 477-484;

  2. Salles, B

    1. A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
      J M Barret, P Calsou, A K Larsen and B Salles
      Molecular Pharmacology September 1994, 46 (3) 431-436;

  3. Saltzman, A

    1. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
      K A Berg, W P Clarke, C Sailstad, A Saltzman and S Maayani
      Molecular Pharmacology September 1994, 46 (3) 477-484;

  4. Shimada, T

    1. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;

  5. Sjöqvist, F

    1. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
      I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg
      Molecular Pharmacology September 1994, 46 (3) 452-459;

  6. Smith, K E

    1. The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;

  7. Sun, W M

    1. Specificity and directionality of thiol effects on sinusoidal glutathione transport in rat liver.
      S C Lu, J Kuhlenkamp, J L Ge, W M Sun and N Kaplowitz
      Molecular Pharmacology September 1994, 46 (3) 578-585;

T

  1. Toyohira, Y

    1. Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;

  2. Tsutsui, M

    1. Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;

V

  1. Vaysse, P J

    1. The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;

W

  1. Wang, Q

    1. Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma-aminobutyric acid type A receptor.
      M Gyenes, Q Wang, T T Gibbs and D H Farb
      Molecular Pharmacology September 1994, 46 (3) 542-549;

  2. Watson, M A

    1. Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
      M Yamada, M Yamada, M A Watson and E Richelson
      Molecular Pharmacology September 1994, 46 (3) 470-476;

  3. Weinshank, R L

    1. The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;

  4. Whiting, P J

    1. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
      X Peng, V Gerzanich, R Anand, P J Whiting and J Lindstrom
      Molecular Pharmacology September 1994, 46 (3) 523-530;

  5. Wigler, P W

    1. Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;

  6. Wilken, G H

    1. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

  7. Williams, K

    1. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
      K Williams
      Molecular Pharmacology September 1994, 46 (3) 531-541;

Y

  1. Yamada, M

    1. Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
      M Yamada, M Yamada, M A Watson and E Richelson
      Molecular Pharmacology September 1994, 46 (3) 470-476;
    2. Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
      M Yamada, M Yamada, M A Watson and E Richelson
      Molecular Pharmacology September 1994, 46 (3) 470-476;

  2. Yamamoto, H

    1. Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;

  3. Yamazaki, H

    1. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;

  4. Yanagihara, N

    1. Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;

  5. Yue, Q Y

    1. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
      I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg
      Molecular Pharmacology September 1994, 46 (3) 452-459;

Z

  1. Zhu, X

    1. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density.
      X Zhu, S Gilbert, M Birnbaumer and L Birnbaumer
      Molecular Pharmacology September 1994, 46 (3) 460-469;
Back to top

In this issue

Advertisement